BRIEF-Bayer says to evaluate Riociguat in new indication

FRANKFURT, June 3 Tue Jun 3, 2014 2:34am EDT

Related Topics

FRANKFURT, June 3 (Reuters) - Bayer AG : * Says Bayer to evaluate riociguat in new indication * Says phase iib study to investigate riociguat in pulmonary hypertension

associated with idiopathic interstitial pneumonia

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.